解除LOX-ing瘤免疫障碍物 癌症免疫障碍物
Tuyen T Dang1, Srinivas Malladi2
1Department of Pathology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Developmental cell
|December 2, 2025
概括
研究人员确定了两种不同的脏细胞癌瘤瘤的亚型. 一种攻击性亚型 (TT1) 具有在免疫抑制微环境中表达LOX的癌细胞,不包括CD8+T细胞.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 细胞癌 (RCC) 可以在血管内形成瘤血栓.
- 了解这些瘤血栓的异质性对于有效的治疗策略至关重要.
研究的目的:
- 识别和表征细胞癌瘤瘤的不同分子亚型.
- 阐明这些亚型的细胞组成和微环境特征.
主要方法:
- 瘤血栓样本的转录组分析.
- 免疫组织化学用于识别特定的细胞群和标记物.
主要成果:
- 鉴定了两种转录上不同的RCC瘤血栓亚型.
- 积极的TT1亚型表现出LOX表达的癌细胞.
- TT1亚型的微环境具有免疫抑制作用,包括THBS2+纤维细胞和GPNMB+巨细胞.
- CD8+ T细胞被排除在TT1亚型微环境之外.
结论:
- RCC瘤血栓是异质的,有不同的亚型.
- TT1亚型的特点是特定的细胞参与者和免疫抑制的微环境.
- 这些发现为RCC瘤血栓的生物学和潜在的治疗点提供了洞察力.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


